JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.4
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 14, Issue 2 (2022)
Iran J War Public Health 2022, 14(2): 119-123 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2022/03/11 | Accepted: 2022/04/1 | Published: 2022/05/30
Received: 2022/03/11 | Accepted: 2022/04/1 | Published: 2022/05/30
How to cite this article
Oleiwi S, Al-Taie A, Al-Hilali K. Risk Factors for Diabetic Nephropathy in Diabetic Patients. Iran J War Public Health 2022; 14 (2) :119-123
URL: http://ijwph.ir/article-1-1126-en.html
URL: http://ijwph.ir/article-1-1126-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Department of Nursing, Alsafwa University College, Karbala, Iraq
Abstract (1539 Views)
Aims: Diabetic nephropathy is one of the consequences of type 1 and type 2 diabetes and one of the main causes of End-Stage Renal Disease (ESRD) as well as an important risk factor for cardiovascular morbidity and death. The aim of this study was to identify the risk factors for diabetic nephropathy in diabetic patients.
Instruments & Methods: In this cross-sectional descriptive study, 121 patients (66 females and 55 males) with type 2 diabetes in Karbala, Iraq from October 2019 to April 2021were studied. In the first stage, a complete history of the patients was taken and then a physical examination was performed. After that, 5 ml of aspirated blood and 100 ml of urine were collected from each patient and both were sent to the laboratory for biochemical tests and urinalysis. The collected data were statistically analyzed using SPSS 22 software and Chi-square test.
Findings: Out of 121 diabetic patients, 77 (63.6%) had diabetic nephropathy. The incidence of diabetic nephropathy was higher in men than women. There was a significant relationship between age, persistent hyperglycemia, obesity, and duration of diabetes with diabetic nephropathy (p<0.05).
Conclusion: Age, persistent hyperglycemia, obesity and duration of diabetes are involved in the development of diabetic nephropathy in diabetic patients.
Instruments & Methods: In this cross-sectional descriptive study, 121 patients (66 females and 55 males) with type 2 diabetes in Karbala, Iraq from October 2019 to April 2021were studied. In the first stage, a complete history of the patients was taken and then a physical examination was performed. After that, 5 ml of aspirated blood and 100 ml of urine were collected from each patient and both were sent to the laboratory for biochemical tests and urinalysis. The collected data were statistically analyzed using SPSS 22 software and Chi-square test.
Findings: Out of 121 diabetic patients, 77 (63.6%) had diabetic nephropathy. The incidence of diabetic nephropathy was higher in men than women. There was a significant relationship between age, persistent hyperglycemia, obesity, and duration of diabetes with diabetic nephropathy (p<0.05).
Conclusion: Age, persistent hyperglycemia, obesity and duration of diabetes are involved in the development of diabetic nephropathy in diabetic patients.
Keywords:
References
1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 Suppl 1:S81-90. [Link] [DOI:10.2337/dc14-S081]
2. Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes. 2009;10 Suppl 12:3-12. [Link] [DOI:10.1111/j.1399-5448.2009.00568.x]
3. Galtier F. Definition, epidemiology, risk factors. Diabetes Metab. 2010;36(6 Pt 2):628-51. [Link] [DOI:10.1016/j.diabet.2010.11.014]
4. Lim AK. Diabetic nephropathy - complications and treatment. Int J Nephrol Renovasc Dis. 2014;7:361-81. [Link] [DOI:10.2147/IJNRD.S40172]
5. Anderson AR, Christian sen JS, Anderson JK, Kreiner S, Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983;25(6):496-501. [Link] [DOI:10.1007/BF00284458]
6. Groop PH, Thomas MC, Moran JL, Wadèn J, Thorn LM, et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes. 2009;58(7):1651-8. [Link] [DOI:10.2337/db08-1543]
7. Orchard TJ, Secrest AM, Miller RG, Costacou T. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia. 2010;53(11):2312-9. [Link] [DOI:10.1007/s00125-010-1860-3]
8. Bruno G, Merletti F, Bargero G, Novelli G, Melis D, et al. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. Diabetologia. 2007;50(5):941-8. [Link] [DOI:10.1007/s00125-007-0616-1]
9. Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013;24(2):302-8. [Link] [DOI:10.1681/ASN.2012070718]
10. Thomas MC, Weekes AJ, Broadley OJ, Cooper ME, Mathew TH. The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Med J Aust. 2006;185(3):140-4. [Link] [DOI:10.5694/j.1326-5377.2006.tb00499.x]
11. Dwyer JP, Parving HH, Hunsicker LG, Ravid M, Remuzzi G, Lewis JB. Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND study. Cardiorenal Med. 2012;2(1):1-10. [Link] [DOI:10.1159/000333249]
12. American Diabetes Association. Nephropathy in diabetes. Diabetes Care. 2004;27:S79-83. [Link] [DOI:10.2337/diacare.27.2007.S79]
13. Myo Clinic. Diabetic nephropathy (kidney disease) [Internet]. Scottsdale, Arizona: Myo Clinic; 2020 [cited 2021 Apr 1]. Available from: https://www.mayoclinic.org/diseases-conditions/diabetic-nephropathy/symptoms-causes/syc-20354556 [Link]
14. Rabkin R. Diabetic nephropathy. Clin Cornerstone. 2003;5(2): 1-11. [Link] [DOI:10.1016/S1098-3597(03)90014-7]
15. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet. 1998;352(9123):213-9. [Link] [DOI:10.1016/S0140-6736(98)01346-4]
16. Gheith O, Farouk N, Nampoory N, Halim MA, Al- Otaibi T. Diabetic kidney disease: world wide difference of prevalence and risk factors. J Nephropharmacol. 2015;5(1):49-56. [Link]
17. Mooyaart AL, Valk EJJ, Van Es LA, Bruijn JA, de Heer E, et al. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia. 2011;54(3):544-53. [Link] [DOI:10.1007/s00125-010-1996-1]
18. MyDr. Diabetic nephropathy [Internet]. MyDr; 2020 [cited 2021 Apr 1]. Available from: https://www.mydr.com.au/diabetic-nephropathy/ [Link]
19. Satko SG, Longefeld CD, Daeihagh P, Bowden DW, Rich SS, Freeman BI. Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis. 2002;40(3):489-94. [Link] [DOI:10.1053/ajkd.2002.34888]
20. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, knowler WC. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabtologia. 1990,33(7):438-43. [Link] [DOI:10.1007/BF00404096]
21. Young BA, Maynard C, Boyko EJ. Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans.Diabetes Care. 2003;26(8):2392-9. [Link] [DOI:10.2337/diacare.26.8.2392]
22. Mooyarrt AL. Genetic associations in diabetic nephropathy. Clin Exp Nephrol. 2014;18(2):197-200. [Link] [DOI:10.1007/s10157-013-0874-9]
23. Marric Bilkan C. Obesity and diabetic kidney disease. Med Clin North Am. 2013;97(1):59-74. [Link] [DOI:10.1016/j.mcna.2012.10.010]
24. Eknoyan G. Obesity, diabetes, and chronic kidney disease. Curr Diab Rep. 2007;7(6):449-53. [Link] [DOI:10.1007/s11892-007-0076-5]
25. Parving HH, Smith UM, Hammel E, Mathiesen ER, Rossing P, Nielsen F, Gall MA. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Dis. 1993;22(1):188-95. [Link] [DOI:10.1016/S0272-6386(12)70185-3]
26. Parving HH, Andersen S, Jacobsen P, Christensen PK, Rossing K, et al. Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points. Semin Nephrol. 2004;24(2):147-57. [Link] [DOI:10.1016/j.semnephrol.2003.11.003]
27. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood). 2008;233(1):4-11. [Link] [DOI:10.3181/0705-MR-134]
28. Weatherspoon D, Seymour T. Diabetic nephropathy or kidney disease [Internet]. Cheltenham: Medical News Today; 2019 [cited 2021 May 9]. Available from: https://www.medicalnewstoday.com/articles/319686. [Link]
29. Batuman V. What is the age distribution for diabetic nephropathy? [Internet]. New York: Medscape; 2021 cited 2021 May 9]. Available from: https://www.medscape.com/answers/238946-42544/what-is-the-age-distribution-for-diabetic-nephropathy. [Link]
30. Prakash S, O' Hare AM. Interaction of aging and chronic kidney disease. Semin Nephrol. 2009;29(5):497-503. [Link] [DOI:10.1016/j.semnephrol.2009.06.006]
31. Yu MK, Lyles CR, Bent-Shaw LA, Young BA. Risk factor, age and sex differences in chronic kidney disease prevalence in a diabetic cohort: the pathways study. Am J Nephrol. 2012;36(3):245-51. [Link] [DOI:10.1159/000342210]
32. Thomas MC, Tikellis C, Burns WM, Bialkowski K, Cao Z, et al. Interactions between renin angiotensin system and advanced glycation in the kidney. J Am Soc Nephrol. 2005;16(10):2976-84. [Link] [DOI:10.1681/ASN.2005010013]
33. Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci. 2002;324(3):127-37. [Link] [DOI:10.1097/00000441-200209000-00003]
34. de Bore, DCCT/EDIC Research Group. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37(1):24-30. [Link] [DOI:10.2337/dc13-2113]